Bodyport
Predicting and preventing heart disease.
Bodyport’s cardiovascular sensing weight scale and predictive algorithms detect early changes in cardiac function to help prevent avoidable hospitalizations. Bodyport is initially targeting heart failure, a chronic condition affecting over 6M Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year). Bodyport’s novel scale measures cardiac output, congestion, heart rate, and other leading indicators of cardiovascular health — all in the same step patients already take to weigh themselves. Companion algorithms and software empower care teams to quickly identify at-risk patients and remotely optimize their therapy to prevent deterioration.
- Website
- bodyport.com
- City
- San Francisco
- Country
- United States
- YC batch
- Summer 2015
- Team
- 19 people
- Stage
- Growth stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run bodyport.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Bodyport across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Bodyport's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
